PIGA, Antonio Giulio
PIGA, Antonio Giulio
SCIENZE CLINICHE E BIOLOGICHE
A 1-year randomized controlled trial of deferasirox versus deferoxamine for myocardial iron removal in beta-thalassemia major (CORDELIA).
2014-01-01 Pennell DJ;Porter JB;Piga A;Lai Y;El-Beshlawy A;Belhoul KM;Elalfy M;Yesilipek A;Kilinç Y;Lawniczek T;Habr D;Weisskopf M;Zhang Y;Aydinok Y
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study
2015-01-01 De Montalembert, Mariane; Abboud, Miguel R.; Fiquet, Anne; Inati, Adlette; Lebensburger, Jeffrey D.; Kaddah, Normeen; Mokhtar, Galila; Piga, Antonio; Halasa, Natasha; Inusa, Baba; Rees, David C.; Heath, Paul T.; Telfer, Paul; Driscoll, Catherine; Al Hajjar, Sami; Tozzi, Alberto; Jiang, Qin; Emini, Emilio A.; Gruber, William C.; Gurtman, Alejandra; Scott, Daniel A.
A child with hyperferritinemia: case report
2011-01-01 M. Serra; F. Longo; A. Roetto; A. Sandri; A. Piga
A multi-center safety trial of the oral iron chelator deferiprone.
1998-01-01 COHEN A; GALANELLO R; PIGA A; VULLO C; TRICTA F
A new fast-moving variant causing erythrocytosis and mild hemolysis: Hb Gàmbara [beta 82(EF6)Lys-->Glu]
1997-01-01 IVALDI G ;SCIMÈ-DEGANI V ;DAVID O ;BAFFICO M ;BALDI M ;LEONE D ;MAZZOCCO M ;LEONE L ;PIGA A ;FURIAN E ;RICCO G
A newly-characterized alpha-thalassaemia-1 deletion removes the entire alpha-like globin gene cluster in an Italian family.
1991-01-01 FORTINA P.; DIANZANI I.; SERRA A.; GOTTARDI E.; SAGLIO G.; FARINASSO L.; PIGA A.; GABUTTI V.; CAMASCHELLA C.
A phase 2 study of the safety, tolerability and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload
2012-01-01 E. J. Neufeld; R. Galanello; V. Viprakasit; Y. Aydinok; A. Piga; P. Harmatz; G. L. Forni; F. T. Shah; R. F. Grace; J. B. Porter; J. C. Wood; J. Peppe; A. Jones; H. Y. Rienhoff
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia
2006-01-01 CAPPELLINI MD; COHEN A; PIGA A; BEJAOUI M; PERROTTA S; AGAOGLU L; AYDINOK Y; KATTAMIS A; KILINC Y; PORTER J; CAPRA M; GALANELLO R; FATTOUM S; DRELICHMAN G; MAGNANO C; VERISSIMO M; THANASSIOU-METAXA M; GIARDINA P; KOURAKLI-SYMEONIDIS A; JANKA-SCHAUB G; COATES T; VERMYLEN C; OLIVIERI N; THURET I; OPITZ H; RESSAYRE-DJAFFER C; MARKS P; ALBERTI D
A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia
2006-01-01 GALANELLO R; KATTAMIS A; PIGA A; FISCHER R; LEONI G; LADIS V; VOI V; LUND U; TRICTA F
A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4
2002-01-01 A. ROETTO; A.T. MERRYWEATHER-CLARKE; F. DARAIO; K. LIVESEY; J.J. POINTON; G. BARBABIETOLA; A. PIGA; P.H. MACKIE; K.J. ROBSON; C. CAMASCHELLA
Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia.
1997-01-01 GIARDINI C ;GALIMBERTI M ;LUCARELLI G ;POLCHI P ;ANGELUCCI E ;BARONCIANI D ;ERER B ;GAZIEV D ;PIGA A ;DI GREGORIO F ;ROMEO MA ;MANGIAGLI A ;PETRELLI E ;MURETTO P
Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial.
2013-01-01 Fernandes JL;Sampaio EF;Fertrin K;Coelho OR;Loggetto S;Piga A;Verissimo M;Saad ST
Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia
2019-01-01 Aydinok Y.; Piga A.; Origa R.; Mufti N.; Erickson A.; North A.; Waldhaus K.; Ernst C.; Lin J.-S.; Huang N.; Benjamin R.J.; Corash L.
Anemie ” eds, McGraw-Hill, Milano 1998, p 95-133.
1998-01-01 Garofalo F; Sacchetti L; Piga A; Ramenghi U
Assessing the efficacy of EBM teaching in a clinical setting
2005-01-01 Gardois, Paolo; Grillo, Gaetano; Lingua, Carla; Jourdan, Annalisa; Piga, Antonio; Fronteddu, Silvia
Assessment and management of iron overload in β-thalassaemia major patients during the 21st century: a real-life experience from the Italian Webthal project.
2013-01-01 Piga A;Longo F;Musallam KM;Cappellini MD;Forni GL;Quarta G;Chiavilli F;Commendatore F;Mulas S;Caruso V;Galanello R
Atrial fibrillation in β-thalassemia Major Patients: Diagnosis, Management and Therapeutic Options
2018-01-01 Barbero U, Fornari F, Guarguagli S, Gaglioti CM, Longo F, Doronzo B, Anselmino M, Piga A.
Behaviour of myeloid precursors in homozygous beta thalassaemia.
1980-01-01 GABUTTI V; MINIERO R; PIGA A; INCARBONE E; SACCHETTI L; BALEGNO G
Blood pressure and heart rate in young thalassemia major patients.
1998-01-01 VEGLIO F ;MELCHIO R ;RABBIA F ;MOLINO P ;GENOVA GC ;MARTINI G ;SCHIAVONE D ;PIGA A ;CHIANDUSSI L
Bone density and metabolism in thalassaemia.
1998-01-01 LALA R; CHIABOTTO P; DI STEFANO M; ISAIA GC; GAROFALO F; PIGA A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A 1-year randomized controlled trial of deferasirox versus deferoxamine for myocardial iron removal in beta-thalassemia major (CORDELIA). | 2014 | Pennell DJ;Porter JB;Piga A;Lai Y;El-Beshlawy A;Belhoul KM;Elalfy M;Yesilipek A;Kilinç Y;Lawniczek T;Habr D;Weisskopf M;Zhang Y;Aydinok Y | |
| 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study | 2015 | De Montalembert, Mariane; Abboud, Miguel R.; Fiquet, Anne; Inati, Adlette; Lebensburger, Jeffrey D.; Kaddah, Normeen; Mokhtar, Galila; Piga, Antonio; Halasa, Natasha; Inusa, Baba; Rees, David C.; Heath, Paul T.; Telfer, Paul; Driscoll, Catherine; Al Hajjar, Sami; Tozzi, Alberto; Jiang, Qin; Emini, Emilio A.; Gruber, William C.; Gurtman, Alejandra; Scott, Daniel A. | |
| A child with hyperferritinemia: case report | 2011 | M. Serra; F. Longo; A. Roetto; A. Sandri; A. Piga | |
| A multi-center safety trial of the oral iron chelator deferiprone. | 1998 | COHEN A; GALANELLO R; PIGA A; VULLO C; TRICTA F | |
| A new fast-moving variant causing erythrocytosis and mild hemolysis: Hb Gàmbara [beta 82(EF6)Lys-->Glu] | 1997 | IVALDI G ;SCIMÈ-DEGANI V ;DAVID O ;BAFFICO M ;BALDI M ;LEONE D ;MAZZOCCO M ;LEONE L ;PIGA A ;FURIAN E ;RICCO G | |
| A newly-characterized alpha-thalassaemia-1 deletion removes the entire alpha-like globin gene cluster in an Italian family. | 1991 | FORTINA P.; DIANZANI I.; SERRA A.; GOTTARDI E.; SAGLIO G.; FARINASSO L.; PIGA A.; GABUTTI V.; CAMASCHELLA C. | |
| A phase 2 study of the safety, tolerability and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload | 2012 | E. J. Neufeld; R. Galanello; V. Viprakasit; Y. Aydinok; A. Piga; P. Harmatz; G. L. Forni; F. T. Shah; R. F. Grace; J. B. Porter; J. C. Wood; J. Peppe; A. Jones; H. Y. Rienhoff | |
| A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia | 2006 | CAPPELLINI MD; COHEN A; PIGA A; BEJAOUI M; PERROTTA S; AGAOGLU L; AYDINOK Y; KATTAMIS A; KILINC Y; PORTER J; CAPRA M; GALANELLO R; FATTOUM S; DRELICHMAN G; MAGNANO C; VERISSIMO M; THANASSIOU-METAXA M; GIARDINA P; KOURAKLI-SYMEONIDIS A; JANKA-SCHAUB G; COATES T; VERMYLEN C; OLIVIERI N; THURET I; OPITZ H; RESSAYRE-DJAFFER C; MARKS P; ALBERTI D | |
| A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia | 2006 | GALANELLO R; KATTAMIS A; PIGA A; FISCHER R; LEONI G; LADIS V; VOI V; LUND U; TRICTA F | |
| A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4 | 2002 | A. ROETTO; A.T. MERRYWEATHER-CLARKE; F. DARAIO; K. LIVESEY; J.J. POINTON; G. BARBABIETOLA; A. PIGA; P.H. MACKIE; K.J. ROBSON; C. CAMASCHELLA | |
| Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia. | 1997 | GIARDINI C ;GALIMBERTI M ;LUCARELLI G ;POLCHI P ;ANGELUCCI E ;BARONCIANI D ;ERER B ;GAZIEV D ;PIGA A ;DI GREGORIO F ;ROMEO MA ;MANGIAGLI A ;PETRELLI E ;MURETTO P | |
| Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial. | 2013 | Fernandes JL;Sampaio EF;Fertrin K;Coelho OR;Loggetto S;Piga A;Verissimo M;Saad ST | |
| Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia | 2019 | Aydinok Y.; Piga A.; Origa R.; Mufti N.; Erickson A.; North A.; Waldhaus K.; Ernst C.; Lin J.-S.; Huang N.; Benjamin R.J.; Corash L. | |
| Anemie ” eds, McGraw-Hill, Milano 1998, p 95-133. | 1998 | Garofalo F; Sacchetti L; Piga A; Ramenghi U | |
| Assessing the efficacy of EBM teaching in a clinical setting | 2005 | Gardois, Paolo; Grillo, Gaetano; Lingua, Carla; Jourdan, Annalisa; Piga, Antonio; Fronteddu, Silvia | |
| Assessment and management of iron overload in β-thalassaemia major patients during the 21st century: a real-life experience from the Italian Webthal project. | 2013 | Piga A;Longo F;Musallam KM;Cappellini MD;Forni GL;Quarta G;Chiavilli F;Commendatore F;Mulas S;Caruso V;Galanello R | |
| Atrial fibrillation in β-thalassemia Major Patients: Diagnosis, Management and Therapeutic Options | 2018 | Barbero U, Fornari F, Guarguagli S, Gaglioti CM, Longo F, Doronzo B, Anselmino M, Piga A. | |
| Behaviour of myeloid precursors in homozygous beta thalassaemia. | 1980 | GABUTTI V; MINIERO R; PIGA A; INCARBONE E; SACCHETTI L; BALEGNO G | |
| Blood pressure and heart rate in young thalassemia major patients. | 1998 | VEGLIO F ;MELCHIO R ;RABBIA F ;MOLINO P ;GENOVA GC ;MARTINI G ;SCHIAVONE D ;PIGA A ;CHIANDUSSI L | |
| Bone density and metabolism in thalassaemia. | 1998 | LALA R; CHIABOTTO P; DI STEFANO M; ISAIA GC; GAROFALO F; PIGA A |